• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[明斯特标准:在Preserflo®微型分流器植入后的情况下进行改良Paul®植入。视频文章]

[Münster standard: modified Paul® implantation in a condition following Preserflo® MicroShunt implantation. Video article].

作者信息

Brücher Viktoria C, Zimmermann Julian A, Storp Jens J, Eter Nicole

机构信息

Klinik für Augenheilkunde, Universitätsklinikum Münster, Domagkstr. 15, 48149, Münster, Deutschland.

出版信息

Ophthalmologie. 2023 Oct;120(10):1056-1059. doi: 10.1007/s00347-023-01914-5. Epub 2023 Sep 18.

DOI:10.1007/s00347-023-01914-5
PMID:37721622
Abstract

OBJECTIVE OF SURGERY

The aim of this surgical technique is the modified placement of a Paul® implant (Fa. Advanced Ophthalmic Innovations, Singapur) in eyes after failure of Preserflo® MicroShunt (Fa. Santen, Osaka, Japan) implantation for the best possible adjustment of the intraocular pressure.

INDICATIONS

The technique presented here is intended for patients suffering from more complex glaucomas, which were unsuccessfully previously treated with a Preserflo® Microshunt (Santen Inc.).

SURGICAL TECHNIQUE

The special feature of the Münster standard is the choice of the surgical field and the waiver of a further tunnel placement. The patients receive a Paul® implant in the same quadrant as the previously inserted Preserflo® MicroShunt implant (superior temporal). The latter is explanted after preparation of the conjunctiva and priming of the Paul® implant with a Prolene 6.0 suture and fixation of the plate. In order to carry out the implantation of the Paul® tube through the existing 25-gauge tunnel, the latter is dilated laterally with an iris spatula under positioning of the anterior chamber. A surgical video, which is available online, shows the surgical technique in detail. ADVANTAGES OF THE MüNSTER STANDARD: The superior temporal surgical access promises easier handling. The fact that there is no need for a new tunnel effectively saves surgery time and is expected to reduce endothelial cell loss as only one tube remains in place in comparison to two anterior chamber tubes.

摘要

手术目的

本手术技术的目的是在Preserflo®微型分流器(日本大阪参天公司)植入失败后,对Paul®植入物(新加坡先进眼科创新公司)进行改良放置,以尽可能最佳地调节眼压。

适应症

此处介绍的技术适用于患有更复杂青光眼的患者,这些患者先前使用Preserflo®微型分流器(参天公司)治疗失败。

手术技术

明斯特标准的特点是手术区域的选择以及无需进一步放置隧道。患者在与先前插入的Preserflo®微型分流器植入物相同的象限(颞上象限)接受Paul®植入物。在准备结膜并用6.0普理灵缝线对Paul®植入物进行灌注并固定板后,将后者取出。为了通过现有的25号隧道植入Paul®管,在前房定位下用虹膜铲将隧道向侧面扩张。一个在线提供的手术视频详细展示了手术技术。

明斯特标准的优势

颞上手术入路便于操作。无需新的隧道这一事实有效节省了手术时间,并且预计可减少内皮细胞损失,因为与两根前房管相比,仅一根管子留在眼内。

相似文献

1
[Münster standard: modified Paul® implantation in a condition following Preserflo® MicroShunt implantation. Video article].[明斯特标准:在Preserflo®微型分流器植入后的情况下进行改良Paul®植入。视频文章]
Ophthalmologie. 2023 Oct;120(10):1056-1059. doi: 10.1007/s00347-023-01914-5. Epub 2023 Sep 18.
2
Case report: Surgical management of vitreous obstruction following PreserFlo ® MicroShunt implantation.病例报告:PreserFlo® 微型分流器植入术后玻璃体阻塞的手术治疗
Am J Ophthalmol Case Rep. 2023 Nov 27;32:101967. doi: 10.1016/j.ajoc.2023.101967. eCollection 2023 Dec.
3
Endothelial cell loss 5 years after Preserflo MicroShunt implantation: About two cases.Preserflo微型分流器植入5年后的内皮细胞丢失:约2例。
Am J Ophthalmol Case Rep. 2021 Dec 8;25:101238. doi: 10.1016/j.ajoc.2021.101238. eCollection 2022 Mar.
4
Detailed intraocular pressure curve by telemetric tonometry with an implanted pressure sensor before and after PreserFlo MicroShunt implantation: a case report.PreserFlo微分流器植入前后通过植入式压力传感器进行遥测眼压测量得到的详细眼压曲线:病例报告
Ther Adv Ophthalmol. 2023 Jan 22;15:25158414221149927. doi: 10.1177/25158414221149927. eCollection 2023 Jan-Dec.
5
Ab externo implantation of the MicroShunt, a poly (styrene--isobutylene--styrene) surgical device for the treatment of primary open-angle glaucoma: a review.用于治疗原发性开角型青光眼的聚(苯乙烯-异丁烯-苯乙烯)手术装置MicroShunt的外部植入:综述
Eye Vis (Lond). 2019 Nov 15;6:36. doi: 10.1186/s40662-019-0162-1. eCollection 2019.
6
Novel Surgical Techniques to Control Flow With PreserFlo MicroShunt for Late Hypotony After Baerveldt Drainage Device Implantation.用于控制PreserFlo微分流器血流的新型手术技术,用于Baerveldt引流装置植入术后晚期低眼压。
J Glaucoma. 2022 Oct 1;31(10):e101-e104. doi: 10.1097/IJG.0000000000002061. Epub 2022 Jun 3.
7
PreserFlo Microshunt for the management of intraocular pressure elevation in iridocorneal endothelial syndrome.PreserFlo微型分流器用于治疗虹膜角膜内皮综合征引起的眼压升高。
Am J Ophthalmol Case Rep. 2023 Sep 22;32:101932. doi: 10.1016/j.ajoc.2023.101932. eCollection 2023 Dec.
8
Safety and Efficacy of the Preserflo Microshunt in Refractory Glaucoma: A One-Year Study.Preserflo微分流器治疗难治性青光眼的安全性和有效性:一项为期一年的研究。
J Clin Med. 2022 Nov 29;11(23):7086. doi: 10.3390/jcm11237086.
9
Posterior chamber implantation of a Preserflo Microshunt in a patient with a compromised endothelium.在后房植入 Preserflo Microshunt 治疗内皮功能障碍患者。
Arch Soc Esp Oftalmol (Engl Ed). 2022 Mar;97(3):161-164. doi: 10.1016/j.oftale.2022.02.002. Epub 2022 Feb 23.
10
Efficacy and Safety of PreserFlo MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study.原发性开角型青光眼滤过术后失败眼应用 PreserFlo 微导管的疗效和安全性:一项回顾性研究。
Adv Ther. 2021 Aug;38(8):4403-4412. doi: 10.1007/s12325-021-01811-w. Epub 2021 Jul 12.

引用本文的文献

1
[Frequency and distribution of the active agent of intravitreal injections in German centers 2015-2021-An oregis study].[2015 - 2021年德国各中心玻璃体内注射活性药物的频率与分布——一项奥雷吉斯研究]
Ophthalmologie. 2024 Mar;121(3):196-206. doi: 10.1007/s00347-024-01986-x. Epub 2024 Feb 5.

本文引用的文献

1
Surgical technique, perioperative management and early outcome data of the PAUL® glaucoma drainage device.PAUL® 青光眼引流装置的手术技术、围手术期管理和早期结果数据。
Eye (Lond). 2022 Oct;36(10):1905-1910. doi: 10.1038/s41433-021-01737-1. Epub 2021 Sep 20.
2
Treatment Outcomes Using the PAUL Glaucoma Implant to Control Intraocular Pressure in Eyes with Refractory Glaucoma.使用 PAUL 青光眼植入物控制难治性青光眼眼内压的治疗结果。
Ophthalmol Glaucoma. 2020 Sep-Oct;3(5):350-359. doi: 10.1016/j.ogla.2020.05.001. Epub 2020 May 11.
3
Five-Year Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study.
艾哈迈德与贝尔维尔德比较研究及艾哈迈德对比贝尔维尔德研究的五年汇总数据分析。
Am J Ophthalmol. 2017 Apr;176:118-126. doi: 10.1016/j.ajo.2017.01.003. Epub 2017 Jan 17.
4
The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes.艾哈迈德对 Baerveldt 研究:五年治疗结果。
Ophthalmology. 2016 Oct;123(10):2093-102. doi: 10.1016/j.ophtha.2016.06.035. Epub 2016 Aug 17.
5
Five-year treatment outcomes in the Ahmed Baerveldt comparison study.艾哈迈德·贝尔费尔特比较研究中的五年治疗结果。
Ophthalmology. 2015 Feb;122(2):308-16. doi: 10.1016/j.ophtha.2014.08.043. Epub 2014 Oct 17.
6
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.五年随访后的 Tube Versus Trabeculectomy(TVT)研究中的治疗结果。
Am J Ophthalmol. 2012 May;153(5):789-803.e2. doi: 10.1016/j.ajo.2011.10.026. Epub 2012 Jan 15.
7
The number of people with glaucoma worldwide in 2010 and 2020.2010年和2020年全球青光眼患者人数。
Br J Ophthalmol. 2006 Mar;90(3):262-7. doi: 10.1136/bjo.2005.081224.